Fusion technology company Shine has been issued a conditional commitment for a loan of up to $263 million by the Department of Energy’s Office of Energy Dominance Financing (EDF) to support the construction of the company’s medical isotope production facility in Janesville, Wis.

According to the Council on Radionuclides and Radiopharmaceuticals, more than 82,000 nuclear imaging procedures using nuclear medicine are performed throughout the world every day. To administer these vital medical procedures, radiopharmaceutical companies and hospitals rely on a handful of producers of medical radioisotopes.